Insulin resistance is an underlying mechanism of impaired glucose metabolism during nilotinib therapy
- PMID: 30054949
- DOI: 10.1002/ajh.25232
Insulin resistance is an underlying mechanism of impaired glucose metabolism during nilotinib therapy
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
